Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis. Drugs that inhibit angiogenesis can starve the tumor of nutrients. VEGF (vascular endothelial growth factor) is a key molecule in this process. Bevacizumab, a VEGF inhibitor, is used in treating various cancers by blocking blood vessel formation.